Endo International Plc (ENDP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Endo International Plc (ENDP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7308
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies. It sells generic products principally in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women’s health, among others. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrinology and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors, to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc (ENDP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Endo International Plc, Medical Equipment, Deal Details 11
Private Equity 11
Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For US$130 Million 11
Partnerships 12
Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12
Debt Offering 13
Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13
Auxilium Pharma Completes Public Offering Of Notes Due 2018 For US$350 Million 14
Asset Transactions 15
Trendlines Acquires Intellectual Property from Endo 15
Acquisition 16
Par Formulations to Acquire Wintac 16
Par Pharma Acquires Innoteq for USD27 Million 17
Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18
Endo Health Solutions Completes Acquisition Of Paladin Labs For US$1.6 Billion 19
Par Pharma Acquires JHP Group for USD488 Million 22
Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23
Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24
Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For US$26.2 Million 25
Endo International Plc – Key Competitors 26
Endo International Plc – Key Employees 27
Endo International Plc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
Strategy And Business Planning 31
Jul 21, 2017: Endo to Restructure Manufacturing Network 31
Financial Announcements 32
Aug 08, 2018: Endo reports second-quarter 2018 financial results 32
May 08, 2018: Endo Reports First-Quarter 2018 Financial Results 34
Feb 27, 2018: Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results 36
Nov 09, 2017: Endo Reports Third-Quarter 2017 Financial Results 38
Aug 08, 2017: Endo Reports Second-Quarter 2017 Financial Results 40
May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 42
Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 45
Corporate Communications 48
Aug 02, 2018: Endo announces appointment of Laure Park as senior vice president investor relations and corporate affairs 48
Nov 08, 2017: Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram 49
Legal and Regulatory 50
Apr 02, 2018: Endo Agrees to Extend Temporary Stay of FDA Litigation 50
Aug 07, 2017: Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims 51
Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 52
Other Significant Developments 53
Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Endo International Plc, Medical Equipment, Key Facts, 2017 2
Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endo International Plc, Deals By Market, 2012 to YTD 2018 9
Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For US$130 Million 11
Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12
Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13
Auxilium Pharma Completes Public Offering Of Notes Due 2018 For US$350 Million 14
Trendlines Acquires Intellectual Property from Endo 15
Par Formulations to Acquire Wintac 16
Par Pharma Acquires Innoteq for USD27 Million 17
Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18
Endo Health Solutions Completes Acquisition Of Paladin Labs For US$1.6 Billion 19
Par Pharma Acquires JHP Group for USD488 Million 22
Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23
Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24
Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For US$26.2 Million 25
Endo International Plc, Key Competitors 26
Endo International Plc, Key Employees 27
Endo International Plc, Other Locations 29
Endo International Plc, Subsidiaries 29

List of Figures
Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endo International Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Endo International Plc (ENDP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GFI Informatique:企業の戦略・SWOT・財務分析
    GFI Informatique - Strategy, SWOT and Corporate Finance Report Summary GFI Informatique - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Iberdrola SA (IBE)-エネルギー分野:企業M&A・提携分析
    Summary Iberdrola, S.A. (Iberdrola) is an electric utility. The company generates, trades, transmits, distributes and markets electricity and gas. It operates hydroelectric, thermal and nuclear power plants in Spain and other countries. The company also involved in the production of electricity from …
  • Walsin Lihwa Corporation:企業の戦略・SWOT・財務情報
    Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report Summary Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Southern Company Gas:企業の戦略的SWOT分析
    Southern Company Gas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Respiri Ltd (RSH):医療機器:M&Aディール及び事業提携情報
    Summary Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company’s prop …
  • Xero Ltd (XRO):企業の財務・戦略的SWOT分析
    Xero Ltd (XRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Takasago International Corporation (4914):企業の財務・戦略的SWOT分析
    Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • SandRidge Energy, Inc. (SD)-石油・ガス分野:企業M&A・提携分析
    Summary SandRidge Energy, Inc. (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Finastra Group Holdings Limited:企業の戦略・SWOT・財務情報
    Finastra Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Finastra Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務分析
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Shionogi Inc:企業の戦略的SWOT分析
    Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Central Electricity Generating Co:企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • H&R GmbH & Co KGaA (2HR):企業の財務・戦略的SWOT分析
    H&R GmbH & Co KGaA (2HR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Laurentian Bank of Canada:企業の戦略・SWOT・財務情報
    Laurentian Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary Laurentian Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Monogram Biosciences Inc:企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆